🇺🇸 FDA
Patent

US 12414995

Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer

granted A61KA61K31/138A61K31/337

Quick answer

US patent 12414995 (Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer) held by Northwestern University expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/138, A61K31/337, A61K31/506, A61K45/06